blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1467695

EP1467695 - HIV INTEGRASE INHIBITORS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  07.07.2006
Database last updated on 04.11.2024
Most recent event   Tooltip25.07.2008Change - representativepublished on 27.08.2008  [2008/35]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[N/P]
Former [2004/43]For all designated states
Bristol-Myers Squibb Company
P.O. Box 4000, Route 206 and Provinceline Road
Princeton, NJ 08543-4000 / US
Inventor(s)01 / WALKER, Michael A.
25 Royal Oak Drive
Durham, CT 06422 / US
02 / BANVILLE, Jacques
1209 Girard
St. Hubert, Québec J4T 1H3 / CA
03 / REMILLARD, Roger
13 des Cedres
Napierville, Québec J0J 1L0 / CA
04 / PLAMONDON, Serge
705 du Cabestan
Ste-Catherine, Québec J0L 1E0 / CA
 [2004/43]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2004/43]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date02804741.306.12.2002
[2004/43]
WO2002US39092
Priority number, dateUS20010339674P12.12.2001         Original published format: US 339674 P
[2004/43]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03049690
Date:19.06.2003
Language:EN
[2003/25]
Type: A2 Application without search report 
No.:EP1467695
Date:20.10.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 19.06.2003 takes the place of the publication of the European patent application.
[2004/43]
Search report(s)International search report - published on:US22.01.2004
ClassificationIPC:A61K6/00
[2004/43]
CPC data not yet available
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/43]
Extension statesAL08.07.2004
LT08.07.2004
LV08.07.2004
MK08.07.2004
RO08.07.2004
TitleGerman:HIV-INTEGRASEHEMMER[2004/43]
English:HIV INTEGRASE INHIBITORS[2004/43]
French:INHIBITEURS DE L'INTEGRASE DU VIH[2004/43]
Entry into regional phase08.07.2004National basic fee paid 
08.07.2004Search fee paid 
08.07.2004Designation fee(s) paid 
08.07.2004Examination fee paid 
Examination procedure02.07.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
08.07.2004Amendment by applicant (claims and/or description)
08.07.2004Examination requested  [2004/43]
03.07.2006Application withdrawn by applicant  [2006/32]
Fees paidRenewal fee
14.12.2004Renewal fee patent year 03
15.12.2005Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational searchWO0000458  [ ] (DAIICHI SEIYAKU CO [JP], et al);
 [A]  - USUI H. ET AL., "Preparation of tartaric acid derivatives as squalens synthase inhibitors", CAPLUS, Database accession no. 132:78549, XP002964974
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.